Review of literature and clinical practice experience for the therapeutic management of Morgellons disease

Abstract

AbstractMorgellons disease (MD) is a rare and contentious health condition characterized by dermatological symptoms including slow‐healing skin lesions ‘attributed’ to fibres emerging from or under the skin. Patients also report sensations of crawling, biting and infestation with inanimate objects. This review examines the aetiology, patient characteristics, epidemiology, historical context, correlation with Lyme disease, role of internet, impact on quality of life and treatment approaches for MD. Despite ongoing debate, MD is not officially recognized in medical classifications, with differing views on its aetiology. Some link MD to Lyme disease, while others view it as a variant of delusional infestation. The literature suggests both psychiatric and environmental factors may contribute. The manuscript explores the association with substance abuse, psychiatric comorbidities, infectious agents and the role of internet communities in shaping perceptions. MD's impact on quality of life is significant, yet often overlooked. Treatment approaches are varied due to limited evidence, with low‐dose antipsychotics being considered effective, but patient beliefs may influence adherence. A patient‐centred, multidisciplinary approach is emphasized, considering both the physical and psychological dimensions of MD. Addressing the controversies surrounding MD while focusing on patient well‐being remains a critical challenge for healthcare professionals.